Skip to main content
Top
Published in: BMC Public Health 1/2019

Open Access 01-12-2019 | Fibromyalgia | Research article

Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain

Authors: Jesús Castro-Marrero, Mónica Faro, María Cleofé Zaragozá, Luisa Aliste, Tomás Fernández de Sevilla, José Alegre

Published in: BMC Public Health | Issue 1/2019

Login to get access

Abstract

Background

Few reports have examined the association between unemployment and work disability in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME). This study explored the key determinants of work disability in a CFS/ME cohort.

Methods

A community-based prospective study included 1086 CFS/ME patients aged 18–65 years. Demographic and clinical characteristics and outcome measures were recorded. Multiple linear regression analysis was performed to identify key risk indicators of work disability.

Results

Four hundred and fifty patients with CFS/ME were employed (41.4%) and 636 were unemployed (58.6%). Older age at pain onset (OR: 1.44; 95% CI: 1. 12–1.84, autonomic dysfunction (OR: 2.21; 95% CI: 1.71–2.87), neurological symptom (OR: 1.66; 95% CI: 1. 30–2.13) and higher scores for fatigue (OR: 2.61; 95% CI: 2.01–3.39), pain (OR: 2.09; 95% CI: 1.47–2.97), depression (OR: 1.98; 95% CI: 1. 20–3.26), psychopathology (OR: 1.98; 95% CI: 1.51–2.61) and sleep dysfunction (OR: 1.47; 95% CI: 1. 14–1.90) were all associated with a higher risk of work disability due to illness.

Conclusions

Using an explanatory approach, our findings suggest that unemployment is consistently associated with an increased risk of work disability due to CFS/ME, although further more rigorous research is now needed to help in targeting interventions at the workplace.
Literature
1.
go back to reference Castro-Marrero J, Sáez-Francàs N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017;174:345–69.CrossRef Castro-Marrero J, Sáez-Francàs N, Santillo D, Alegre J. Treatment and management of chronic fatigue syndrome/myalgic encephalomyelitis/myalgic encephalomyelitis: all roads lead to Rome. Br J Pharmacol. 2017;174:345–69.CrossRef
2.
go back to reference Committee on the Diagnostic Criteria for ME/CFS; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic encephalomyelitis/chronic fatigue syndrome/myalgic encephalomyelitis: redefining an illness. Washington (DC): National Academies Press (US); 2015. Available from: https://www.ncbi.nlm.nih.gov/books/NBK284897 Committee on the Diagnostic Criteria for ME/CFS; Board on the Health of Select Populations; Institute of Medicine. Beyond Myalgic encephalomyelitis/chronic fatigue syndrome/myalgic encephalomyelitis: redefining an illness. Washington (DC): National Academies Press (US); 2015. Available from: https://​www.​ncbi.​nlm.​nih.​gov/​books/​NBK284897
3.
go back to reference Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome/myalgic encephalomyelitis: prevalence in a Pacific northwest health care system. Ann Intern Med. 1995;123:81–8.CrossRef Buchwald D, Umali P, Umali J, et al. Chronic fatigue and the chronic fatigue syndrome/myalgic encephalomyelitis: prevalence in a Pacific northwest health care system. Ann Intern Med. 1995;123:81–8.CrossRef
4.
go back to reference Nacul LC, Lacerda E, Pheby D, et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 2011;28:9–91. Nacul LC, Lacerda E, Pheby D, et al. Prevalence of myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) in three regions of England: a repeated cross-sectional study in primary care. BMC Med. 2011;28:9–91.
5.
go back to reference Reyes M, Gary HE Jr, Dobbins JG, et al. Descriptive epidemiology of chronic fatigue syndrome/myalgic encephalomyelitis: surveillance in four US cities, September 1989 through august 1993. Morbid Mortal Week Report Surveil Sum. 1997;46:1–13. Reyes M, Gary HE Jr, Dobbins JG, et al. Descriptive epidemiology of chronic fatigue syndrome/myalgic encephalomyelitis: surveillance in four US cities, September 1989 through august 1993. Morbid Mortal Week Report Surveil Sum. 1997;46:1–13.
6.
go back to reference Fukuda K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome/myalgic encephalomyelitis: a comprehensive approach to its definition and study. Ann Inter Med. 1994;121:953–9.CrossRef Fukuda K, Strauss SE, Hickie I, et al. The chronic fatigue syndrome/myalgic encephalomyelitis: a comprehensive approach to its definition and study. Ann Inter Med. 1994;121:953–9.CrossRef
7.
go back to reference Carruthers B, Jain A, DeMeirleir K, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols (Canadian case definition). J Chronic Fatigue Syndr. 2003;11:7–115.CrossRef Carruthers B, Jain A, DeMeirleir K, et al. Myalgic encephalomyelitis/chronic fatigue syndrome: clinical working case definition, diagnostic and treatment protocols (Canadian case definition). J Chronic Fatigue Syndr. 2003;11:7–115.CrossRef
8.
go back to reference Castro-Marrero J, Faro M, Aliste L, et al. Comorbid conditions in chronic fatigue syndrome/myalgic encephalomyelitis: findings from a nationwide population-based cohort study. Psychosomatics. 2017;58:533–43.CrossRef Castro-Marrero J, Faro M, Aliste L, et al. Comorbid conditions in chronic fatigue syndrome/myalgic encephalomyelitis: findings from a nationwide population-based cohort study. Psychosomatics. 2017;58:533–43.CrossRef
9.
go back to reference Calvo N, Sàez-Francàs N, Valero S, et al. Comorbid personality disorders in chronic fatigue syndrome/myalgic encephalomyelitis patients: a marker of psychopathological severity. Actas Esp Psiquiatr. 2015;43:58–65.PubMed Calvo N, Sàez-Francàs N, Valero S, et al. Comorbid personality disorders in chronic fatigue syndrome/myalgic encephalomyelitis patients: a marker of psychopathological severity. Actas Esp Psiquiatr. 2015;43:58–65.PubMed
10.
go back to reference Anderson JS, Ferrans CE. The quality of life of persons with chronic fatigue syndrome/myalgic encephalomyelitis. J Nerv Ment Dis. 1997;185:359–67.CrossRef Anderson JS, Ferrans CE. The quality of life of persons with chronic fatigue syndrome/myalgic encephalomyelitis. J Nerv Ment Dis. 1997;185:359–67.CrossRef
11.
go back to reference Lloyd AR, Pender H. The economic impact of chronic fatigue syndrome/myalgic encephalomyelitis. Med J Aust. 1992;157:599–601.PubMed Lloyd AR, Pender H. The economic impact of chronic fatigue syndrome/myalgic encephalomyelitis. Med J Aust. 1992;157:599–601.PubMed
12.
go back to reference Jason LA, Benton MC, Valentine L, et al. The economic impact of ME/CFS: individual and societal costs. Dyn Med. 2008;7:6.CrossRef Jason LA, Benton MC, Valentine L, et al. The economic impact of ME/CFS: individual and societal costs. Dyn Med. 2008;7:6.CrossRef
13.
go back to reference Nyland M, Naess H, Birkeland JS, et al. Longitudinal follow-up of employment status in patients with chronic fatigue syndrome/myalgic encephalomyelitis after mononucleosis. BMJ Open. 2014;26:e005798.CrossRef Nyland M, Naess H, Birkeland JS, et al. Longitudinal follow-up of employment status in patients with chronic fatigue syndrome/myalgic encephalomyelitis after mononucleosis. BMJ Open. 2014;26:e005798.CrossRef
14.
go back to reference Cella M, Sharpe M, Chalder T. Measuring disability in patients with chronic fatigue syndrome/myalgic encephalomyelitis: reliability and validity of the work and social adjustment scale. J Psychosom Res. 2011;71:124–8.CrossRef Cella M, Sharpe M, Chalder T. Measuring disability in patients with chronic fatigue syndrome/myalgic encephalomyelitis: reliability and validity of the work and social adjustment scale. J Psychosom Res. 2011;71:124–8.CrossRef
15.
go back to reference Kelly M, Gagne R, Newman JD, et al. Assessment of fibromyalgia and chronic fatigue syndrome/myalgic encephalomyelitis: a new protocol designed to determine work capability-chronic pain abilities determination (CPAD). Ir Med J. 2008;101:277–8.PubMed Kelly M, Gagne R, Newman JD, et al. Assessment of fibromyalgia and chronic fatigue syndrome/myalgic encephalomyelitis: a new protocol designed to determine work capability-chronic pain abilities determination (CPAD). Ir Med J. 2008;101:277–8.PubMed
16.
go back to reference Hayes MHS, Paterson DG. Experimental development of the graphic rating method. Psychol Bull. 1921;18:98–9. Hayes MHS, Paterson DG. Experimental development of the graphic rating method. Psychol Bull. 1921;18:98–9.
17.
go back to reference Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18:S79–83.CrossRef Fisk JD, Ritvo PG, Ross L, et al. Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994;18:S79–83.CrossRef
18.
go back to reference Fisk JD, Doble SE. Construction and validation of fatigue impact scale for daily administration (D-FIS). Qual Life Res. 2002;11:263–72.CrossRef Fisk JD, Doble SE. Construction and validation of fatigue impact scale for daily administration (D-FIS). Qual Life Res. 2002;11:263–72.CrossRef
19.
go back to reference Alonso J, Prieto L, Antó JM. La versión española del SF-36 health survey (Cuestionario de Salud SF-36): in instrumento Para la medida de los resultados clínicos. [the Spanish version of the SF-36 health survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc). 1995;104:771–6. Alonso J, Prieto L, Antó JM. La versión española del SF-36 health survey (Cuestionario de Salud SF-36): in instrumento Para la medida de los resultados clínicos. [the Spanish version of the SF-36 health survey (the SF-36 health questionnaire): an instrument for measuring clinical results]. Med Clin (Barc). 1995;104:771–6.
20.
go back to reference Derogatis LR. SCL-90-R: administration, scoring & procedures manual-I for the R(evised) version. Clinical psychosomatic research. Baltimore: John Hopkins University School Medicine; 1977. Derogatis LR. SCL-90-R: administration, scoring & procedures manual-I for the R(evised) version. Clinical psychosomatic research. Baltimore: John Hopkins University School Medicine; 1977.
21.
go back to reference Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HAD) in a Spanish population. Gen Hosp Psychiatr. 2003;25:277–83.CrossRef Herrero MJ, Blanch J, Peri JM, et al. A validation study of the hospital anxiety and depression scale (HAD) in a Spanish population. Gen Hosp Psychiatr. 2003;25:277–83.CrossRef
22.
go back to reference Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–221.CrossRef Buysse DJ, Reynolds CF, Monk TH, et al. The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193–221.CrossRef
23.
go back to reference Taylor RR, Kielhofner GW. Work-related impairment and employment-focused rehabilitation options for individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a review. J Mental Health. 2005;14:253–67.CrossRef Taylor RR, Kielhofner GW. Work-related impairment and employment-focused rehabilitation options for individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a review. J Mental Health. 2005;14:253–67.CrossRef
24.
go back to reference Ross SD, Estok RP, Frame D, et al. Disability and chronic fatigue syndrome/myalgic encephalomyelitis: a focus on function. Arch Intern Med. 2004;164:1098–107.CrossRef Ross SD, Estok RP, Frame D, et al. Disability and chronic fatigue syndrome/myalgic encephalomyelitis: a focus on function. Arch Intern Med. 2004;164:1098–107.CrossRef
25.
go back to reference Collado A, Gómez E, Coscolla R, et al. Work, family and social environment in patients with fibromyalgia in Spain: an epidemiological study: EPIFFAC study. BMC Health Serv Res. 2014;14:513.CrossRef Collado A, Gómez E, Coscolla R, et al. Work, family and social environment in patients with fibromyalgia in Spain: an epidemiological study: EPIFFAC study. BMC Health Serv Res. 2014;14:513.CrossRef
26.
go back to reference Collin SM, Crawley E, May MT, et al. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217.CrossRef Collin SM, Crawley E, May MT, et al. The impact of CFS/ME on employment and productivity in the UK: a cross-sectional study based on the CFS/ME national outcomes database. BMC Health Serv Res. 2011;11:217.CrossRef
27.
go back to reference Santamarina-Perez P, Eiroa-Orosa FJ, Rodríguez-Urrutia A, et al. Neuropsychological impairment in female patients with chronic fatigue syndrome/myalgic encephalomyelitis: a preliminary study. Appl Neuropsychol Adult. 2014;21:120–7.CrossRef Santamarina-Perez P, Eiroa-Orosa FJ, Rodríguez-Urrutia A, et al. Neuropsychological impairment in female patients with chronic fatigue syndrome/myalgic encephalomyelitis: a preliminary study. Appl Neuropsychol Adult. 2014;21:120–7.CrossRef
28.
go back to reference Assefi NP, Coy TV, Uslan D, et al. Financial, occupational, and personal consequences of disability in patients with chronic fatigue syndrome/myalgic encephalomyelitis and fibromyalgia compared to other fatiguing conditions. J Rheumatol. 2003;30:804–8.PubMed Assefi NP, Coy TV, Uslan D, et al. Financial, occupational, and personal consequences of disability in patients with chronic fatigue syndrome/myalgic encephalomyelitis and fibromyalgia compared to other fatiguing conditions. J Rheumatol. 2003;30:804–8.PubMed
29.
go back to reference Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med. 2007;6:6.CrossRef Brown MM, Jason LA. Functioning in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: increased impairment with co-occurring multiple chemical sensitivity and fibromyalgia. Dyn Med. 2007;6:6.CrossRef
30.
go back to reference Hadlandsmyth K, Vowles K. Does depression mediate the relation between fatigue severity and disability in chronic fatigue syndrome/myalgic encephalomyelitis sufferers? J Psychosom Res. 2009;66:31–5.CrossRef Hadlandsmyth K, Vowles K. Does depression mediate the relation between fatigue severity and disability in chronic fatigue syndrome/myalgic encephalomyelitis sufferers? J Psychosom Res. 2009;66:31–5.CrossRef
31.
go back to reference Knudsen AK, Henderson M, Harvey SB, et al. Long-term sickness absence among patients with chronic fatigue syndrome/myalgic encephalomyelitis. Br J Psychiatry. 2011;199:430–1.CrossRef Knudsen AK, Henderson M, Harvey SB, et al. Long-term sickness absence among patients with chronic fatigue syndrome/myalgic encephalomyelitis. Br J Psychiatry. 2011;199:430–1.CrossRef
32.
go back to reference Palstam A, Bjersing JL, Mannerkorpi K. Which aspects of health differ between working and non-working women with fibromyalgia? A cross-sectional study of work status and health. BMC Public Health. 2012;12:1076.CrossRef Palstam A, Bjersing JL, Mannerkorpi K. Which aspects of health differ between working and non-working women with fibromyalgia? A cross-sectional study of work status and health. BMC Public Health. 2012;12:1076.CrossRef
33.
go back to reference Nacul LC, Lacerda E, Campion P, et al. The functional status and wellbeing of people with myalgic encephalomyelitis/chronic fatigue syndrome and their careers. BMC Public Health. 2011;11:402.CrossRef Nacul LC, Lacerda E, Campion P, et al. The functional status and wellbeing of people with myalgic encephalomyelitis/chronic fatigue syndrome and their careers. BMC Public Health. 2011;11:402.CrossRef
34.
go back to reference Jason LA, Porter N, Hunnell J, et al. A natural history study of chronic fatigue syndrome/myalgic encephalomyelitis. Rehabil Psychol. 2011;56:32–42.CrossRef Jason LA, Porter N, Hunnell J, et al. A natural history study of chronic fatigue syndrome/myalgic encephalomyelitis. Rehabil Psychol. 2011;56:32–42.CrossRef
35.
go back to reference Jason L, Brown M, Evans M, et al. Measuring substantial reductions in functioning in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Disabil Rehabil. 2011;33:589–98.CrossRef Jason L, Brown M, Evans M, et al. Measuring substantial reductions in functioning in patients with chronic fatigue syndrome/myalgic encephalomyelitis. Disabil Rehabil. 2011;33:589–98.CrossRef
36.
go back to reference Unger ER, Lin JS, Tian H, et al. Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic fatigue syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. Am J Epidemiol. 2017;17:1–10. Unger ER, Lin JS, Tian H, et al. Multi-Site Clinical Assessment of Myalgic Encephalomyelitis/Chronic fatigue syndrome (MCAM): Design and Implementation of a Prospective/Retrospective Rolling Cohort Study. Am J Epidemiol. 2017;17:1–10.
37.
go back to reference Kidd E, Brown A, McManimen S, et al. The Relationship between age and illness duration in chronic fatigue syndrome/myalgic encephalomyelitis. Diagnostics (Basel). 2016;6:E16.CrossRef Kidd E, Brown A, McManimen S, et al. The Relationship between age and illness duration in chronic fatigue syndrome/myalgic encephalomyelitis. Diagnostics (Basel). 2016;6:E16.CrossRef
38.
go back to reference Ciccone DS, Chandler HK, Natelson BH. Illness trajectories in the chronic fatigue syndrome/myalgic encephalomyelitis: a longitudinal study of improvers versus non-improvers. J Nerv Ment Dis. 2010;198:486–93.CrossRef Ciccone DS, Chandler HK, Natelson BH. Illness trajectories in the chronic fatigue syndrome/myalgic encephalomyelitis: a longitudinal study of improvers versus non-improvers. J Nerv Ment Dis. 2010;198:486–93.CrossRef
Metadata
Title
Unemployment and work disability in individuals with chronic fatigue syndrome/myalgic encephalomyelitis: a community-based cross-sectional study from Spain
Authors
Jesús Castro-Marrero
Mónica Faro
María Cleofé Zaragozá
Luisa Aliste
Tomás Fernández de Sevilla
José Alegre
Publication date
01-12-2019
Publisher
BioMed Central
Published in
BMC Public Health / Issue 1/2019
Electronic ISSN: 1471-2458
DOI
https://doi.org/10.1186/s12889-019-7225-z

Other articles of this Issue 1/2019

BMC Public Health 1/2019 Go to the issue